HGK promotes metastatic dissemination in prostate cancer

Abstract Metastasis is the process of cancer cell dissemination from primary tumors to different organs being the bone the preferred site for metastatic homing of prostate cancer (PCa) cells. Prostate tumorigenesis is a multi-stage process that ultimately tends to advance to become metastatic PCa. O...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sara Garcia-Garcia, Maria Rodrigo-Faus, Noelia Fonseca, Sara Manzano, Balázs Győrffy, Alberto Ocaña, Paloma Bragado, Almudena Porras, Alvaro Gutierrez-Uzquiza
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8f492cc077af4106be60cc15dc54728d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8f492cc077af4106be60cc15dc54728d
record_format dspace
spelling oai:doaj.org-article:8f492cc077af4106be60cc15dc54728d2021-12-02T17:47:23ZHGK promotes metastatic dissemination in prostate cancer10.1038/s41598-021-91292-22045-2322https://doaj.org/article/8f492cc077af4106be60cc15dc54728d2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91292-2https://doaj.org/toc/2045-2322Abstract Metastasis is the process of cancer cell dissemination from primary tumors to different organs being the bone the preferred site for metastatic homing of prostate cancer (PCa) cells. Prostate tumorigenesis is a multi-stage process that ultimately tends to advance to become metastatic PCa. Once PCa patients develop skeletal metastases, they eventually succumb to the disease. Therefore, it is imperative to identify essential molecular drivers of this process to develop new therapeutic alternatives for the treatment of this devastating disease. Here, we have identified MAP4K4 as a relevant gene for metastasis in PCa. Our work shows that genetic deletion of MAP4K4 or pharmacological inhibition of its encoded kinase, HGK, inhibits metastatic PCa cells migration and clonogenic properties. Hence, MAP4K4 might promote metastasis and tumor growth. Mechanistically, our results indicate that HGK depleted cells exhibit profound differences in F-actin organization, increasing cell spreading and focal adhesion stability. Additionally, HGK depleted cells fails to respond to TNF-α stimulation and chemoattractant action. Moreover, here we show that HGK upregulation in PCa samples from TCGA and other databases correlates with a poor prognosis of the disease. Hence, we suggest that it could be used as prognostic biomarker to predict the appearance of an aggressive phenotype of PCa tumors and ultimately, the appearance of metastasis. In summary, our results highlight an essential role for HGK in the dissemination of PCa cells and its potential use as prognostic biomarker.Sara Garcia-GarciaMaria Rodrigo-FausNoelia FonsecaSara ManzanoBalázs GyőrffyAlberto OcañaPaloma BragadoAlmudena PorrasAlvaro Gutierrez-UzquizaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sara Garcia-Garcia
Maria Rodrigo-Faus
Noelia Fonseca
Sara Manzano
Balázs Győrffy
Alberto Ocaña
Paloma Bragado
Almudena Porras
Alvaro Gutierrez-Uzquiza
HGK promotes metastatic dissemination in prostate cancer
description Abstract Metastasis is the process of cancer cell dissemination from primary tumors to different organs being the bone the preferred site for metastatic homing of prostate cancer (PCa) cells. Prostate tumorigenesis is a multi-stage process that ultimately tends to advance to become metastatic PCa. Once PCa patients develop skeletal metastases, they eventually succumb to the disease. Therefore, it is imperative to identify essential molecular drivers of this process to develop new therapeutic alternatives for the treatment of this devastating disease. Here, we have identified MAP4K4 as a relevant gene for metastasis in PCa. Our work shows that genetic deletion of MAP4K4 or pharmacological inhibition of its encoded kinase, HGK, inhibits metastatic PCa cells migration and clonogenic properties. Hence, MAP4K4 might promote metastasis and tumor growth. Mechanistically, our results indicate that HGK depleted cells exhibit profound differences in F-actin organization, increasing cell spreading and focal adhesion stability. Additionally, HGK depleted cells fails to respond to TNF-α stimulation and chemoattractant action. Moreover, here we show that HGK upregulation in PCa samples from TCGA and other databases correlates with a poor prognosis of the disease. Hence, we suggest that it could be used as prognostic biomarker to predict the appearance of an aggressive phenotype of PCa tumors and ultimately, the appearance of metastasis. In summary, our results highlight an essential role for HGK in the dissemination of PCa cells and its potential use as prognostic biomarker.
format article
author Sara Garcia-Garcia
Maria Rodrigo-Faus
Noelia Fonseca
Sara Manzano
Balázs Győrffy
Alberto Ocaña
Paloma Bragado
Almudena Porras
Alvaro Gutierrez-Uzquiza
author_facet Sara Garcia-Garcia
Maria Rodrigo-Faus
Noelia Fonseca
Sara Manzano
Balázs Győrffy
Alberto Ocaña
Paloma Bragado
Almudena Porras
Alvaro Gutierrez-Uzquiza
author_sort Sara Garcia-Garcia
title HGK promotes metastatic dissemination in prostate cancer
title_short HGK promotes metastatic dissemination in prostate cancer
title_full HGK promotes metastatic dissemination in prostate cancer
title_fullStr HGK promotes metastatic dissemination in prostate cancer
title_full_unstemmed HGK promotes metastatic dissemination in prostate cancer
title_sort hgk promotes metastatic dissemination in prostate cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8f492cc077af4106be60cc15dc54728d
work_keys_str_mv AT saragarciagarcia hgkpromotesmetastaticdisseminationinprostatecancer
AT mariarodrigofaus hgkpromotesmetastaticdisseminationinprostatecancer
AT noeliafonseca hgkpromotesmetastaticdisseminationinprostatecancer
AT saramanzano hgkpromotesmetastaticdisseminationinprostatecancer
AT balazsgyorffy hgkpromotesmetastaticdisseminationinprostatecancer
AT albertoocana hgkpromotesmetastaticdisseminationinprostatecancer
AT palomabragado hgkpromotesmetastaticdisseminationinprostatecancer
AT almudenaporras hgkpromotesmetastaticdisseminationinprostatecancer
AT alvarogutierrezuzquiza hgkpromotesmetastaticdisseminationinprostatecancer
_version_ 1718379480988254208